Microtube Array Membranes for Recoverable Cell Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current encapsulated cell therapy (ECT) systems for treating neurodegenerative diseases face challenges with either macroscale systems having a long diffusion distance and low effective surface area or microscale systems being non-recoverable, limiting the ability to retrieve encapsulated cells in case of adverse effects, which is a barrier for patient biosafety.
Innovation Solution
The development of Microtube Array Membranes (MTAMs) made from ultra-thin polysulfone or PLGA-PLLA fibers, allowing for the encapsulation of hybridoma or stem cells, providing a recoverable and biocompatible platform with a short diffusion distance and high surface area for efficient nutrient and substance transfer.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Area of stationary object
If microscale encapsulated cell therapy systems are used, then diffusion surface area is increased and nutrient transfer efficiency is improved, but the system becomes non-recoverable and patient biosafety is compromised
Solution Approach 1:
The encapsulated cell device is divided into multiple modular microcapsules that can be individually retrieved through the bloodstream, allowing partial or complete recovery of the therapy system while maintaining high surface area for diffusion
Solution Approach 2:
A retrievable anchoring mechanism or magnetic nanoparticle intermediary is introduced that allows external control and retrieval of the microscale encapsulated cells without compromising their diffusion efficiency or immune evasion capabilities
2Reliability
If macroscale encapsulated cell therapy systems are used, then device recoverability is maintained, but diffusion distance is long and effective surface area is reduced
Solution Approach 1:
The system transitions from macroscale single-chamber encapsulation to microscale multi-chamber encapsulation, distributing cells across numerous small compartments that collectively provide large surface area while maintaining short diffusion distances within each microcapsule
3Productivity
If encapsulated cells are used to treat neurodegenerative diseases, then therapeutic substance production is improved, but the ability to retrieve cells in case of adverse effects is limited
Solution Approach 1:
Magnetic nanoparticles or responsive anchoring molecules are introduced as intermediaries that enable external control and retrieval of encapsulated cells through magnetic field application or specific binding agents, allowing rapid removal in case of adverse effects while maintaining continuous therapeutic production
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The MTAMs enable effective delivery of anti-Tau antibodies or therapeutic factors across the blood-brain barrier, improving cognitive function and memory in animal models of neurodegenerative diseases while allowing for potential retrieval of encapsulated cells, enhancing patient safety.
Implementation Method 1
The porous membrane confers sufficient protection while ensuring supply of oxygen and nutrients diffuse through for cell proliferation, migration, and differentiation
Implementation Method 2
providing a recoverable and biocompatible platform with a short diffusion distance and high surface area for efficient nutrient and substance transfer
Data Source
AI summary
A pharmaceutical composition for treating neurodegenerative diseases of the brain is provided and including cells encapsulated by microtubular array membranes (MTAMs). The material of the microtubular array membrane is Polysulfone (PSF) or PLGA-PLLA copolymer. The cells include hybridoma cells capable of secreting anti-Tau antibodies or human umbilical cord mesenchymal stem cells (hUC-MSCs). The pharmaceutical composition could be implanted into a living body for treating neurodegenerative diseases of the brain in a subject in need thereof, in order to improve the cognitive dysfunction.